HeartSciences EBITDA Margin 2022-2024 | HSCS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for HeartSciences (HSCS) over the last 10 years. The current EBITDA margin for HeartSciences as of January 31, 2024 is .
| HeartSciences EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-01-31 | $0.00B | $-0.01B | inf% |
| 2023-10-31 | $0.00B | $-0.01B | inf% |
| 2023-04-30 | $0.00B | $-0.01B | inf% |
| 2023-01-31 | $0.00B | $-0.01B | inf% |
| 2022-04-30 | $0.00B | $-0.01B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.006B | $0.000B |
| HeartSciences is an artificial intelligence powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The company's product candidate includes the MyoVista(R) wavECG(TM) or the MyoVista(R). HeartSciences , formerly known as Heart Test Laboratories Inc., is based in Southlake, TX. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.170B | 20.41 |
| Inspire Medical Systems (INSP) | United States | $7.442B | 0.00 |
| Axonics (AXNX) | United States | $3.438B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.304B | 0.00 |
| 10x Genomics (TXG) | United States | $3.115B | 0.00 |
| Azenta (AZTA) | United States | $3.074B | 250.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.887B | 0.00 |
| Enovis (ENOV) | United States | $2.865B | 21.24 |
| Hims & Hers Health (HIMS) | United States | $2.646B | 0.00 |
| Privia Health (PRVA) | United States | $2.284B | 101.32 |
| Schrodinger (SDGR) | United States | $1.715B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 48.10 |
| Phreesia (PHR) | United States | $1.274B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.854B | 0.00 |
| Standard BioTools (LAB) | United States | $0.688B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.638B | 0.00 |
| Talkspace (TALK) | United States | $0.456B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.400B | 0.00 |
| Pulmonx (LUNG) | United States | $0.370B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.324B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.225B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.210B | 0.00 |
| Outset Medical (OM) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.161B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.09 |
| 111 (YI) | China | $0.098B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.067B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| ETAO (ETAO) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |